Lilly

In News

Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning - Bloomberg.com

Bloomberg.com - Sep 18, 2026

US FDA approves Lilly's breast cancer drug combo - Reuters

Reuters - Sep 18, 2026

Magical Sisters Lulutto Lilly Anime Spotlights CompatoLilly in New Character Trailer - Crunchyroll

Crunchyroll - Sep 18, 2026

Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds - Yahoo Finance

Yahoo Finance - Sep 17, 2026

Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo - Fierce Pharma

Fierce Pharma - Sep 18, 2026

Lilly's GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Sep 19, 2026

Better Buy for Cautious Investors: Eli Lilly vs Costco - The Motley Fool

The Motley Fool - Sep 18, 2026

Lilly-backed Orbis does up to $1.4B macrocycle deal with Novo - Endpoints News

Endpoints News - Sep 17, 2026

Utah Couple Claims Vet Euthanized Dog Instead of Giving Allergy Shot - People.com

People.com - Sep 17, 2026

Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation? - Yahoo Finance

Yahoo Finance - Sep 18, 2026

U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer - Eli Lilly

Eli Lilly - Sep 18, 2026

Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech - Fierce Biotech

Fierce Biotech - Sep 15, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment